U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets

Patent 5281585 Issued on January 25, 1994. Estimated Expiration Date: Icon_subject November 6, 2012. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Compositions containing new indole derivatives and their use in pharmacology
Patent #: 4064255
Issued on: 12/20/1977
Inventor: Champseix ,   et al.

Substituted amides and sulfonamides containing a heterocyclic group having antiinflammatory activity
Patent #: 4122255
Issued on: 10/24/1978
Inventor: Krapcho

4-Phenoxymethyl-piperidines
Patent #: 4243807
Issued on: 01/06/1981
Inventor: Friebe ,   et al.

Phenylsulphonamide derivatives, anti-arrhythymic compositions and use
Patent #: 4622331
Issued on: 11/11/1986
Inventor: Jozic

Glutaramide diuretic agents
Patent #: 5030654
Issued on: 07/09/1991
Inventor: Barnish, et al.

Anti-thrombotic peptide and pseudopeptide derivatives Patent #: 5064814
Issued on: 11/12/1991
Inventor: Klein, et al.

Inventors

Assignee

Application

No. 972668 filed on 11/06/1992

US Classes:

514/79, Nitrogen containing hetero ring514/80, Polycylo ring system having a ring nitrogen in the system514/86, Nitrogen atoms occupy 1 and 3- positions514/89, Hetero ring is six-membered and includes only one ring nitrogen514/90, Chalcogen in the six-membered hetero ring514/91, Hetero ring is five-membered514/92, Two or more hetero atoms in the five-membered ring514/211.08, Plural ring nitrogens in the seven-membered hetero ring514/211.15, Additional nitrogen containing hetero ring attached directly or indirectly to the seven-membered hetero ring by nonionic bonding514/212.08, Additional hetero ring attached directly or indirectly by nonionic bonding to the seven-membered hetero ring514/218, Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms514/222.2, Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members514/222.5, Three or more ring hetero atoms in the six-membered hetero ring514/253.01, The additional hetero ring is six-membered consisting of one nitrogen and five carbon atoms514/256, 1,3-diazines (e.g., pyrimidines, etc.)514/299, Bicyclo ring system having the six-membered hetero ring as one of the cyclos514/316, Plural piperidine rings514/318, The additional ring is a six-membered hetero ring consisting of one nitrogen and five carbon atoms514/326, The additional ring is a hetero ring514/331, Nitrogen attached indirectly to the piperidine ring by nonionic bonding514/460, Chalcogen bonded directly to ring carbon of the hetero ring514/463, Plural ring oxygens in the hetero ring514/492, Heavy metal containing DOAI514/524, The cyano is bonded directly to a benzene ring544/3, Six-membered hetero ring consists of sulfur, nitrogen, and carbon544/7, Plural nitrogens in the six-membered hetero ring (e.g., thiatriazines, etc.)544/316, Nitrogen attached directly or indirectly to the diazine ring by nonionic bonding544/360, Six-membered ring consisting of one nitrogen and five carbons (e.g., pyridine, etc.)546/22, Phosphorus attached indirectly to the six-membered hetero ring by nonionic bonding546/125, Additional hetero ring containing546/183, Chalcogen bonded directly to ring carbon of the bicyclo ring system546/187, Additional hetero ring containing546/188, Chalcogen attached directly to a ring carbon of a piperidine ring by nonionic bonding546/193, Pyridine ring or partially hydrogenated pyridine ring546/201, Bicyclo ring system which is indole (including hydrogenated)546/207, The additional ring is a hetero ring546/208, Ring nitrogen in the additional hetero ring546/210, Plural ring nitrogens in the additional hetero ring546/212, The additional hetero ring consists of one sulfur and four carbons546/233, Acyclic nitrogen bonded directly to a -C(=X)- group, wherein X is chalcogen546/300Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding

Examiners

Primary: Cintins, Marianne M.
Assistant: Hydorn, Michael B.

Attorney, Agent or Firm

Foreign Patent References

  • 352249 EP. 01/13/1990
  • 372486 EP. 06/13/1990
  • 381033 EP. 08/13/1990
  • 384362 EP. 08/13/1990
  • 405537 EP. 01/13/1991
  • 0478328A1 EP. 04/13/1992
  • 0478362A2 EP. 04/13/1992

International Classes

A61K 031/16
A61K 031/445
A61K 031/395
C07D 417/06
C07D 401/06

Abstract

Fibrinogen receptor antagonists of the formula: ##STR1## are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.

PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?